关键词：骨和矿物质疾病；骨质疏松症；诊断测试
摘 要：Bone and mineral disorders are usually caused by abnormalities in minerals such as calcium, phosphorus, vitamin D, and in bone structure or bone mass. Osteoporosis, Paget's disease, and osteogenesis imperfecta are the most common bone diseases. Other diseases, such as arthritis and cancer and their respective treatments, also have adverse effects on bone. Bone and mineral diagnostic tests are used for the diagnosis and assessment of changes in response to bone disorder therapy. These tests are performed using various technologies such as the enzyme-linked immunosorbent assay (ELISA), chemiluminescence immunoassay (CLIA), and radioimmunoassay (RIA) techniques.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Reimbursement and coverage: An overview

Current scenario: Validating diagnostic tests

Reimbursement structure in the US

Reimbursement structure in EU

Prevailing issues of reimbursement policies

PART 07: Market segmentation by application

Vitamin D testing

Bone metabolism

PART 08: Market segmentation by technology

ELISA

CLIA

Other tests

PART 09: Market segmentation by product

Assays/consumables

Instruments

PART 10: Geographical segmentation

Bone and mineral diagnostic testing market in

Americas

Bone and mineral diagnostic testing market in EMEA

Bone and mineral diagnostic testing market in APAC

PART 11: Market drivers

Increasing incidence of bone disorders

Early diagnosis and preventive medicine

Increase in geriatric population

PART 12: Impact of drivers

PART 13: Market challenges

Pricing erosion in established countries

Limited detection capability and complexity

Reimbursement and regulatory hurdles

PART 14: Impact of drivers and challenges

PART 15: Market trends

Development in automation of assays

Growing focus on emerging countries

Focus on POC diagnostic tests

Increase in awareness and role of government and nonprofit

institutions

PART 16: Vendor landscape

Competitive scenario

Key vendor analysis 2014

Other prominent vendors

PART 17: Key vendor analysis

Abbott Diagnostics

bioMérieux

DiaSorin

Roche Diagnostics

Siemens Healthcare

Quidel

PART 18: Appendix

List of abbreviations

PART 19: Explore Technavio